Close

Jefferies Downgrades Ampio Pharmaceuticals (AMPE) to Hold

August 22, 2014 6:44 AM EDT
Get Alerts AMPE Hot Sheet
Price: $0.03 --0%

Rating Summary:
    4 Buy, 1 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE

Jefferies downgraded Ampio Pharmaceuticals (NYSE: AMPE) from Buy to Hold with a price target of $5.00 (from $14.00).

Analyst Biren Amin said, "We are downgrading AMPE shares to a Hold from a Buy on a lack of confidence in the direction of the Ampion program. The company announced that the PIII STEP trial observed a significant setback when 73% of Ampion clinical supply in STEP may have been exposed to temperatures below 15 degrees Celsius. AMPE expects to disclose full efficacy data upon discussing w/ the FDA, which is anticipated in 3-4 weeks."

The cut FY 2014 EPS from ($0.70) to ($0.75) and FY 2015 EPS from ($0.58) to ($0.69).

For an analyst ratings summary and ratings history on Ampio Pharmaceuticals click here. For more ratings news on Ampio Pharmaceuticals click here.

Shares of Ampio Pharmaceuticals closed at $5.66 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change, Downgrades

Related Entities

Jefferies & Co